News & Analysis as of

Biden Administration Trump Administration Financial Stimulus

Lowenstein Sandler LLP

Paycheck Protection Program: FAQs For Microbusinesses - UPDATED March 2021 #3

On December 27, the President signed into law the Consolidated Appropriations Act, 2021. The Act includes a roughly $900 billion COVID-19 relief package, known as the “Economic Aid to Hard-Hit Small Businesses, Nonprofits and...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, January 2021 # 9

Hogan Lovells on

In Washington: President-elect Joe Biden unveiled the first plan to is two-part $1.9 trillion stimulus package calling on Congress to approve $415 billion in emergency spending to scale up vaccinations, testing, and other...more

Robins Kaplan LLP

Financial Daily Dose 1.13.2021 | Top Story: Visa Jettisons Plaid Takeover After DOJ Antitrust Challenge

Robins Kaplan LLP on

Visa is “abandoning its $5.3 billion planned acquisition of Plaid Inc.,” a fintech startup that the DOJ had called an upstart “but important competitive threat to Visa” in its antitrust lawsuit challenging the deal....more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 17

Hogan Lovells on

In Washington: On Tuesday evening, President Donald Trump threatened to turn a month’s worth of negotiations and passage of the COVID-19 and FY2021 omnibus appropriations bills upside down by suggesting that he might veto...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 16

Hogan Lovells on

In Washington: The House and Senate both passed the $900 billion coronavirus stimulus bill on Monday with overwhelming bipartisan majorities: 359-53 in the House and 92-6 in the Senate. ...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 10

Hogan Lovells on

In Washington: A bipartisan group of lawmakers is splitting its $908 billion coronavirus relief proposal into two packages. The plan reportedly will include a $160 billion proposal that ties together the two most...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 8

Hogan Lovells on

In Washington: The Food and Drug Administration’s (FDA) vaccine advisory panel voted to recommend that the FDA authorize the Pfizer-BioNTech vaccine for emergency use. A Centers for Disease Control and Prevention (CDC)...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 7

Hogan Lovells on

In Washington: The House passed a one-week funding extension (HR 8900) to give lawmakers more time to finalize a fiscal 2021 spending package and coronavirus relief. The vote was 343-67. The measure (HR 8900) now goes to...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 5

Hogan Lovells on

In Washington: President-elect Joe Biden picked California Attorney General Xavier Becerra to be his health secretary. Becerra was a defender of the Affordable Care Act. Separately, Biden picked a Harvard infectious...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, December 2020 # 4

Hogan Lovells on

In Washington: On Thursday, the U.S. experienced the deadliest 24 Hours since the Coronavirus pandemic began as a record 2,777 Americans died in just 24 hours. More than 14 million Americans have now tested positive,...more

Hogan Lovells

Coronavirus: The Hill and the Headlines, November 2020 # 18

Hogan Lovells on

In Washington: On Sunday, White House Coronavirus Task Force coordinator Dr. Deborah Birx warned Americans to “assume that you’re infected” with COVID-19 if you traveled or gathered for Thanksgiving and advised being...more

Seyfarth Shaw LLP

Seyfarth Policy Matters Newsletter - November 2020

Seyfarth Shaw LLP on

Stimulus, Vaccines, and Corona. OH MY! First, The Stimulus.  The status of additional stimulus remains where it has been as we have been tracking it for months, ever since the House passed the HEROES Act: nowhere. While the...more

Robins Kaplan LLP

Financial Daily Dose 11.9.2020 | Top Story: Pfizer’s Vaccine News and Election Certainty Propel Wall Street Futures Skyward

Robins Kaplan LLP on

So . . . .  Nice, quiet week while we were gone, right? Wall Street forecasts are always dicey, but it sure looks like Pfizer’s solid vaccine news (along with this weekend’s newfound presidential certainty) could make for...more

13 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide